Eberle, RahelP.; Hari, Yvonne Ilona; Schürch, Stefan (2017). Transition Metal-based Anticancer Drugs Targeting Nucleic Acids: A Tandem Mass Spectrometric Investigation. CHIMIA, 71(3), pp. 120-123. Schweizerische Chemische Gesellschaft 10.2533/chimia.2017.120
|
Text
2017 Chimia.pdf - Published Version Available under License Publisher holds Copyright. Download (138kB) | Preview |
The search for effective drugs against cisplatin-resistant tumors resulted in a large number of organometallic compounds that are evaluated for their antiproliferative activity. Among the most promising candidates are bent metallocenes based on various transition metal ions and ligands. The elucidation of structural features and the characterization of the interaction of a drug candidate with its target require accurate and sensitive analytical tools. Tandem mass spectrometry is applied to the investigation of the adduct sites and binding patterns of metallodrugs bound to single-stranded oligonucleotides and higher-order nucleic acids. Results reveal the binding specificities of the different metallodrugs and demonstrate the influence they exert on the dissociation pathways of the adducts in the gas-phase.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
08 Faculty of Science > Department of Chemistry, Biochemistry and Pharmaceutical Sciences (DCBP) |
UniBE Contributor: |
Hari, Yvonne Ilona, Schürch, Stefan |
Subjects: |
500 Science > 570 Life sciences; biology 500 Science > 540 Chemistry 500 Science 600 Technology > 610 Medicine & health |
ISSN: |
0009-4293 |
Publisher: |
Schweizerische Chemische Gesellschaft |
Language: |
English |
Submitter: |
Stefan Schürch |
Date Deposited: |
16 Apr 2018 12:41 |
Last Modified: |
05 Dec 2022 15:11 |
Publisher DOI: |
10.2533/chimia.2017.120 |
PubMed ID: |
28351457 |
BORIS DOI: |
10.7892/boris.112529 |
URI: |
https://boris.unibe.ch/id/eprint/112529 |
Actions (login required)
 |
Edit item |